Immunization with a recombinant BibA surface protein confers immunity and protects mice against group B Streptococcus (GBS) vaginal colonization

Full metadata record
DC FieldValueLanguage
dc.contributorCentro de Biotecnologiapt_BR
dc.contributorLab. Bacteriologiapt_BR
dc.contributor.authorSantos, Nayara Fernanda Barros dospt_BR
dc.contributor.authorSilva, Lukas Raposo dapt_BR
dc.contributor.authorCosta, Fagner James Martins Dantaspt_BR
dc.contributor.authorMattos, Daniely Maranhão dept_BR
dc.contributor.authorCarvalho, Eneaspt_BR
dc.contributor.authorFerreira, Luís Carlos de Souzapt_BR
dc.contributor.authorFerreira, Rita de Cássia Cafépt_BR
dc.identifier.citationSantos NFB, Silva LR, Costa FJMD, Mattos DM, Carvalho E, Ferreira LCS, et al. Immunization with a recombinant BibA surface protein confers immunity and protects mice against group B Streptococcus (GBS) vaginal colonization. Vaccine. 2020 June; 38(33):5286-5296pt_BR
dc.description.abstractStreptococcus agalactiae or group B Streptococcus (GBS) is a Gram-positive bacterium divided into ten distinct serotypes that colonizes the vaginal and rectal tracts of approximately 30% of women worldwide. GBS is the leading cause of invasive infection in newborns, causing sepsis, pneumoniae and meningitis. The main strategy to prevent GSB infection in newborns includes the use of intrapartum antibiotic therapy, which does not prevent late-onset diseases and may select resistant bacterial strains. We still do not have a vaccine formulation specific for this pathogen approved for human use. Conserved surface proteins are potential antigens that could be targets for recognition by antibodies and activation of cell opsonization. We used a serotype V GBS (GBS-V)-derived recombinant surface protein, rBibA, and evaluated the potential protective role of the induced antigen-specific antibodies after parenteral or mucosal immunizations in C57BL/6 mice. In vitro and in vivo assays demonstrated that vaccine formulations containing BibA combined with different adjuvants induced serum IgG and/or secreted IgA antibodies, leading to enhanced opsonophagocytosis of GBS-V cells and reduced invasion of epithelial cells. One BibA-based vaccine formulation adjuvanted with a nontoxic derivative of the heat-labile toxin produced by enterotoxigenic Escherichia coli (ETEC) strains was capable of inducing protection against vaginal colonization and lethal parenteral challenge with GBS-V. Serum collected from vaccinated mice conferred passive protection against vaginal colonization in naïve mice challenged with GBS-V. Taken together, the present data demonstrate that the BibA protein is a promising antigen for development of a vaccine to protect against GBS infection.pt_BR
dc.description.sponsorship(FAPESP) Fundação de Amparo à Pesquisa do Estado de São Paulopt_BR
dc.description.sponsorship(CAPES) Coordenação de Aperfeiçoamento de Pessoal de Nível Superiorpt_BR
dc.rightsOpen accesspt_BR
dc.titleImmunization with a recombinant BibA surface protein confers immunity and protects mice against group B Streptococcus (GBS) vaginal colonizationpt_BR
dc.rights.licenseCC BYpt_BR
dc.contributor.external(USP) Universidade de São Paulopt_BR
dc.subject.keywordStreptococcus agalactiaept_BR
dc.subject.keywordvaginal colonizationpt_BR
dc.identifier.citationabntv. 38, n. 33, p. 5286-5296, jul. 2020pt_BR
dc.identifier.citationvancouver2020 July; 38(33):5286-5296pt_BR
dc.contributor.butantanCarvalho, Eneas|:Pesquisador|:Centro de Biotecnologia:Lab. Bacteriologia|:Autor de correspondênciapt_BR
dc.sponsorship.butantan(CAPES) Coordenação de Aperfeiçoamento de Pessoal de Nível Superior¦¦pt_BR
dc.sponsorship.butantan(FAPESP) Fundação de Amparo à Pesquisa do Estado de São Paulo¦¦2004/08836-1pt_BR
item.fulltextCom Texto completo-
Appears in Collections:Artigos de periódicos

Files in This Item:

Size: 2.03 MB
Format: Adobe PDF
Show simple item record

This item is licensed under a Creative Commons License Creative Commons